## Key Points:
– Los Angeles-based Law Offices of Frank R. Cruz invites investors to lead legal action against Outset Medical, Inc. (ticker: OM).
– Class Period: August 1, 2022 – August 7, 2024. Lead Plaintiff Deadline: October 28, 2024.
– Claims were made that Outset Medical concealed critical information from investors.
– Allegations include marketing products without FDA approval and misleading statements affecting business prospects.
Investors with substantial losses are urged to consider taking a leading role in a securities fraud class action lawsuit against Outset Medical, Inc. (OM). The Law Offices of Frank R. Cruz in Los Angeles is offering this opportunity to potentially affected shareholders from August 1, 2022, to August 7, 2024, with a Lead Plaintiff Deadline set for October 28, 2024.
The lawsuit alleges that Outset Medical failed to disclose crucial information to investors during the Class Period. This information includes marketing Tablo products for uses not approved by the FDA, the likelihood of additional FDA applications, and risks of ceasing sales pending approvals. Additionally, the company lacked the resources necessary to support Tablo sales growth. These alleged actions could have adversely impacted the company’s revenue growth and misled investors about Outset Medical’s business operations and prospects.
Investors are advised to monitor updates on Twitter via the Law Offices of Frank R. Cruz’s account at twitter.com/FRC_LAW. For those interested in participating in the class action, no immediate action is required. If further information or clarification is needed regarding this legal matter, investors can reach out to Frank R. Cruz by phone at 310-914-5007, via email at [email protected], or by visiting their website at www.frankcruzlaw.com.
It is important to note that this press release may be subject to Attorney Advertising rules in certain jurisdictions under applicable laws and ethical standards.
